Amgen (AMGN)
(Real Time Quote from BATS)
$313.37 USD
-1.17 (-0.37%)
Updated May 21, 2024 01:12 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Brokerage Reports
Amgen Inc. [AMGN]
Reports for Purchase
Showing records 221 - 240 ( 427 total )
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Q2 Revenue Flat; KRAS Showing Efficacy in Colorectal Cancer - Hold
Provider: G.RESEARCH, LLC
Analyst: HE J
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily
Analyst: Research Department
Company: Amgen Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for AMGN
Provider: Stock Traders Daily